A dual-function variant on chromosome 17 regulates circRNA expression and splicing in multiple sclerosis

This study identifies the dual-function variant rs7214410 on chromosome 17 as a key regulator that modulates both circular RNA expression and gene splicing, thereby refining the genetic susceptibility locus for multiple sclerosis.

The Gist

The Big Picture: A Genetic "Switch" Gone Wrong

Imagine your body is a massive, bustling city. The DNA in your cells is the master blueprint for how that city is built and run. Usually, we think of this blueprint as a list of instructions for building the "machines" of the city (proteins).

But scientists have recently discovered that the blueprint also contains a hidden layer of instructions for circular notes called circRNAs. Think of these circRNAs as sticky notes or circular loops of tape that don't build machines but instead act as traffic controllers, telling the city's machinery when to speed up, slow down, or stop.

Multiple Sclerosis (MS) is like a chaotic traffic jam in the city's central nervous system. The immune system (the city's police force) mistakenly attacks the roads (myelin sheaths), causing inflammation and damage.

This paper asks a simple question: Could a tiny typo in the master blueprint be causing the traffic controllers (circRNAs) to malfunction, leading to the chaos of MS?

---

The Detective Work: Finding the Culprit

The researchers acted like genetic detectives. They had three main tools:

1. The Blueprint (DNA): They looked at the genetic code of people with MS and healthy people.
2. The Traffic Logs (RNA): They measured how many "sticky notes" (circRNAs) were floating around in the blood.
3. The Map (GWAS): They knew exactly where the "danger zones" were on the blueprint where MS usually strikes.

They wanted to find a specific typo (a genetic variant) that did two things at once:

• Changed the number of "sticky notes" (circRNAs).
• Changed how the instructions were cut and pasted (splicing).

The Discovery: The "Double-Action" Switch

After sifting through thousands of data points, they found a very specific location on Chromosome 17 (let's call it "Street 17").

They identified a specific typo, called rs7214410. This typo is special because it acts like a dual-function switch:

1. It breaks the "Sticky Note" factory: When a person has this specific typo, their body produces significantly fewer of a specific circular RNA called hsa_circ_0106983. It's like the factory stopped printing the traffic control notes, leaving the roads unmanaged.
2. It messes up the "Cut and Paste": This same typo also changes how a gene called EFCAB13 is assembled. Imagine a recipe for a cake where the instructions say "add flour, sugar, and eggs." This typo causes the baker to accidentally skip the "sugar" and "eggs" steps. The result is a weird, incomplete cake (a different version of the protein).

The Analogy:
Think of the gene EFCAB13 as a train track.

• Normal Version: The train (the cell's machinery) goes all the way from Station 8 to Station 11, picking up passengers (exons) along the way.
• The "Typo" Version: The track has a broken switch. The train skips Stations 9 and 10 entirely and jumps straight to Station 11.
• The CircRNA Connection: The "Sticky Note" (circRNA) is made from the part of the track that got skipped. Because the track was rerouted, the factory that makes the sticky notes runs out of materials, and fewer notes are produced.

The Verdict: Who is the Real Villain?

For a long time, scientists thought a different typo nearby (called rs11079784) was the main villain causing MS in this area. They thought rs11079784 was the "Lead SNP" (the main suspect).

However, this study found that rs7214410 (the dual-function switch) is actually the real boss.

• It is more strongly linked to the disease than the old suspect.
• It explains why the disease happens: by messing up both the circular RNA traffic controllers and the protein assembly line.

Why Does This Matter?

1. New Clues for Cures: Instead of just looking at the "machines" (proteins) that go wrong in MS, we now know we need to look at the "traffic controllers" (circRNAs) and the "cut-and-paste" instructions.
2. Precision Medicine: If we can figure out exactly how this typo breaks the system, we might be able to design a drug that fixes the "cut-and-paste" error or forces the body to make more of the missing "sticky notes."
3. The Hidden World: This paper proves that the "junk" or "non-coding" parts of our DNA (the parts that don't make proteins) are actually the most important switches for complex diseases like MS.

In a Nutshell

The researchers found a tiny typo in our DNA that acts like a double-edged sword. It breaks the instructions for making a specific circular RNA and also messes up the assembly of a protein. This double trouble seems to be a major reason why some people develop Multiple Sclerosis. It's a huge step forward in understanding the hidden mechanics of the disease.

Technical Summary

1. Problem Statement

Multiple Sclerosis (MS) is a complex autoimmune disease with a multifactorial etiology involving genetic and environmental factors. While Genome-Wide Association Studies (GWAS) have identified over 200 susceptibility loci, the functional mechanisms by which these non-coding genetic variants influence disease risk remain largely unclear.

• The Gap: Most functional annotation of MS variants focuses on protein-coding genes (eQTLs) or microRNAs. The role of circular RNAs (circRNAs)—a class of non-coding RNAs known to be dysregulated in MS—and their genetic regulation via circ-eQTLs is underexplored.
• The Hypothesis: Genetic variants may regulate MS susceptibility by modulating circRNA expression (circ-eQTLs) or by acting as dual-function variants that simultaneously affect circRNA biogenesis and linear gene splicing (sQTLs).

2. Methodology

The study employed a multi-cohort, multi-omics approach combining discovery, validation, and functional assays.

• Cohorts:
  • Discovery Cohort: 30 MS patients and 18 healthy controls (HC) with RNA-seq and whole-genome genotyping (Illumina Global Screening Array).
  • Validation Cohort 1 (Expression): 67 MS and 64 HC for RT-qPCR validation of candidate circRNAs.
  • Validation Cohort 2 (Association): A large case-control study comprising 2,831 MS patients and 3,191 HC from six Spanish centers.
  • Functional Validation: Lymphoblastoid B-cell lines (LCL) and peripheral leukocytes for splicing analysis.
• Experimental Workflow:
  1. circ-eQTL Mapping: A linear regression model (adjusted for disease status and sex) correlated 4.8 million imputed SNPs with 22,835 bona fide circRNAs. Significant hits were filtered by FDR < 0.05 and MAF > 0.1.
  2. Candidate Prioritization: Identified circ-eQTLs were intersected with:
     • Known MS susceptibility regions (GWAS loci).
     • Known Splicing QTLs (sQTLs) from the GTEx database.
  3. Validation:
     • Expression: RT-qPCR using divergent primers to specifically amplify back-spliced junctions.
     • Association: Case-control association testing using SNPassoc in R.
     • Splicing Mechanism: PCR amplification of EFCAB13 exons 8–11 followed by gel electrophoresis and Sanger sequencing to visualize exon skipping events.
  4. Statistical Analysis: Generalized Linear Models (GLM) with Gamma distribution for expression; Kruskal-Wallis and Dunn's tests for splicing band quantification.

3. Key Contributions

• Comprehensive circ-eQTL Atlas: The study identified 42,077 significant cis-circ-eQTLs in peripheral blood leukocytes, a number significantly higher than previous MS-specific studies, establishing a robust map of genetic regulation of circRNAs.
• Identification of a Dual-Function Variant: The study pinpointed rs7214410 on chromosome 17 as a variant with a dual regulatory role:
  1. It acts as a circ-eQTL regulating the expression of hsa_circ_0106983.
  2. It acts as an sQTL affecting the alternative splicing of its host gene, EFCAB13.
• Refinement of MS Susceptibility Locus: The study challenges the previously identified lead SNP for the chromosome 17 MS locus (rs11079784), demonstrating that rs7214410 has a stronger statistical association with MS risk, suggesting it may be the causal variant.

4. Key Results

• Discovery & Prioritization: From the initial 42,077 circ-eQTLs, three candidates were prioritized based on overlap with MS GWAS and GTEx sQTLs.
• Validation of Expression:
  • rs7214410 significantly modulates hsa_circ_0106983 expression ($p < 0.0001$). Individuals with the alternative allele (AG/GG) showed lower circRNA expression compared to the reference homozygote (AA).
  • rs11079784 also modulated hsa_circ_0106983 but showed a weaker association with MS risk.
  • The third candidate (rs6498184) failed validation.
• Association Study:
  • In the large cohort (2,831 MS / 3,191 HC), rs7214410 showed a stronger association with MS ($p = 7.9 \times 10^{-3}$, OR = 1.17) than the previously reported lead SNP rs11079784 ($p = 4.8 \times 10^{-2}$, OR = 0.89).
  • The two SNPs are in linkage disequilibrium ($r^2 = 0.792$), but rs7214410 appears to be the more likely causal driver.
• Splicing Mechanism (sQTL):
  • rs7214410 was confirmed as an sQTL for EFCAB13.
  • Individuals with the risk allele (G) exhibited exon skipping (specifically skipping exons 9 and 10).
  • Gel electrophoresis and sequencing confirmed that the "GG" genotype leads to a loss of the full-length transcript and an increase in the isoform lacking exons 9 and 10.
  • Crucially, while the variant affects splicing and circRNA levels, it did not significantly alter the total expression level of the linear EFCAB13 mRNA.

5. Significance

• Mechanistic Insight: The study provides evidence that MS susceptibility variants can function through non-coding RNA mechanisms (circRNAs) rather than just protein-coding gene expression.
• Dual-Functionality: It highlights a unique biological mechanism where a single SNP regulates both the biogenesis of a circular RNA and the alternative splicing of its host gene, potentially through competition for splicing machinery or structural changes in the pre-mRNA.
• Therapeutic Targeting: By identifying rs7214410 as a superior causal variant over rs11079784, the study refines the target for future functional studies and potential therapeutic interventions in the EFCAB13 locus.
• Broader Implication: The findings suggest that the "missing heritability" in complex diseases may lie in the regulation of non-coding RNA isoforms and splicing events, urging a shift in focus from linear mRNA expression to isoform-specific and circRNA-specific regulation.